Sven Mensing Selected Research

Sven Mensing Research Topics

Disease

11	Infections 04/2022 - 01/2016
7	Body Weight (Weight, Body) 01/2021 - 04/2015
5	Neoplasms (Cancer) 01/2021 - 09/2014
4	Chronic Hepatitis C 01/2020 - 01/2016
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023 - 01/2017
3	Breast Neoplasms (Breast Cancer) 10/2022 - 11/2019
3	Hematologic Neoplasms (Hematological Malignancy) 08/2022 - 01/2017
3	Neutropenia 04/2022 - 01/2017
3	Fibrosis (Cirrhosis) 04/2017 - 01/2017
2	Residual Neoplasm 12/2023 - 01/2021
2	Crohn Disease (Crohn's Disease) 01/2023 - 04/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 10/2019
2	Thrombocytopenia (Thrombopenia) 04/2022 - 09/2014
1	Ulcerative Colitis 01/2023
1	Disease Progression 10/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Edema (Dropsy) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2015

Drug/Important Bio-Agent (IBA)

8	venetoclaxIBA 12/2023 - 01/2017
8	paritaprevirIBA 11/2018 - 01/2016
7	Ritonavir (Norvir)FDA Link 11/2018 - 01/2016
7	ombitasvirIBA 11/2018 - 01/2016
7	Antiviral Agents (Antivirals)IBA 11/2018 - 01/2016
6	CreatinineIBA 01/2021 - 01/2016
5	dasabuvirIBA 11/2018 - 01/2016
4	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 01/2016
3	veliparibIBA 10/2022 - 11/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 11/2019
3	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 11/2019
2	Adalimumab (Humira)FDA Link 01/2023 - 04/2015
2	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2019
2	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2022 - 10/2019
2	AlbuminsIBA 01/2021 - 04/2015
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 01/2016
2	InterferonsIBA 01/2020 - 01/2017
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021
1	Organic Cation Transporter 2IBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Cytochrome P-450 CYP3AIBA 01/2021
1	Cytochrome P-450 CYP2C19IBA 01/2021
1	EnzymesIBA 01/2021
1	budigalimabIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	glecaprevirIBA 01/2020
1	pibrentasvirIBA 01/2020
1	glecaprevir and pibrentasvirIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 11/2019
1	Azacitidine (5 Azacytidine)FDA Link 10/2019
1	Decitabine FDA Link 10/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	depatuxizumab mafodotinIBA 01/2019
1	monomethylauristatin FIBA 01/2019
1	EpitopesIBA 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Antimitotic AgentsIBA 01/2019
1	TabletsIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2016
1	BilirubinIBA 01/2016
1	Monoclonal AntibodiesIBA 04/2015
1	C-Reactive ProteinIBA 04/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015
1	navitoclaxIBA 09/2014

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2016
3	Drug Therapy (Chemotherapy) 04/2022 - 09/2014